TransUnion stock (US89400J1079): shares steady after latest quarterly update and valuation focus

TransUnion shares trade broadly stable on the NYSE following the release of its first-quarter 2026 results in April, as investors reassess the US credit bureau’s earnings profile and valuation metrics against sector peers.

TransUnion shares on the New York Stock Exchange were little changed in recent trading after the US credit bureau reported first-quarter 2026 results in April and provided an update on its business segments, keeping investor attention on earnings trends and valuation multiples in the information services sector.

The stock traded at around USD 73.50 on 06/05/2026 on the NYSE, according to data published by Nasdaq as of 06/05/2026, implying a market capitalization in the mid-single-digit billions of US dollars based on the latest share count disclosed by the company.

TransUnion, headquartered in Chicago in the United States and listed on the NYSE under the ticker TRU, is one of the three major US credit bureaus and operates globally as a data and analytics provider to financial institutions, insurers, telecom operators and other industries.

The company released its first-quarter 2026 earnings on 04/23/2026, reporting revenue of USD 1.10 billion for the quarter ended 03/31/2026 and adjusted diluted earnings per share of USD 0.93, according to the earnings press release published on the same date.

Management said in that 04/23/2026 release that organic growth in the US markets business was supported by demand from financial services clients, while international operations also contributed to top-line expansion in regions such as Latin America and Asia-Pacific.

According to the same 04/23/2026 earnings materials, TransUnion reported that its US markets segment generated a substantial portion of consolidated revenue in the first quarter of 2026, with the remainder coming from international operations and its consumer interactive activities.

For full-year 2026, the company provided guidance on 04/23/2026 indicating that it expects revenue in a range around the low-to-mid USD 4 billion level and adjusted diluted EPS around the mid USD 3 range, based on assumptions for continued demand across its risk, marketing and fraud solutions.

In Germany, TransUnion shares were quoted on Tradegate at about EUR 68.00 on 06/05/2026, offering German retail investors an alternative venue to access the US-listed stock during extended trading hours.

As of: 05.06.2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: TransUnion
• Sector/industry: Credit reporting and data analytics
• Headquarters/country: Chicago, United States
• Core markets: United States, Canada, Latin America, Europe, Asia-Pacific, Africa
• Key revenue drivers: Credit reports and scores, risk and fraud solutions, marketing and audience targeting services, consumer credit monitoring subscriptions
• Home exchange/listing venue: New York Stock Exchange (TRU)
• Trading currency: USD

TransUnion: core business model

TransUnion generates revenue by aggregating and analyzing consumer and business data to deliver credit information, risk decisioning tools and digital marketing solutions to banks, lenders, insurers, telecommunications providers and other corporate clients, while also monetizing consumer-facing credit monitoring and identity protection services.

Valuation metrics and multiples for TransUnion

Investors are closely tracking TransUnion’s valuation metrics following its first-quarter 2026 report on 04/23/2026, which provided updated earnings and cash flow data for the credit bureau’s diversified operations.

Based on a share price of USD 73.50 on 06/05/2026 and the company’s guidance for adjusted diluted EPS around the mid USD 3 range for full-year 2026 as communicated on 04/23/2026, TransUnion’s forward price-to-earnings multiple sits in the low-to-mid 20s, placing it in a similar valuation corridor to other information services and analytics providers with defensive earnings profiles.

According to the 04/23/2026 earnings release, TransUnion also highlighted its focus on deleveraging and disciplined capital allocation, noting that net leverage remained within the company’s targeted range at the end of the first quarter of 2026, which can be relevant for investors assessing enterprise value-based ratios such as EV/EBITDA.

The same 04/23/2026 materials showed that TransUnion continued to generate solid operating cash flow in the quarter ended 03/31/2026, supporting ongoing investments in technology, data assets and new product development, all of which are factors that equity investors often incorporate into their valuation models when comparing the stock with peers in the data and analytics sector.

Dividend payments have historically played a smaller role in TransUnion’s equity story compared with capital deployed for growth and acquisitions, and the 04/23/2026 communications did not indicate a change in that approach for 2026, keeping the focus on earnings growth and multiple expansion rather than income-focused metrics such as dividend yield.

Conclusion

TransUnion’s share price on the NYSE has remained broadly stable around USD 73.50 as of 06/05/2026 while investors digest the first-quarter 2026 results released on 04/23/2026 and the company’s guidance for the remainder of the year.

With a forward P/E ratio in the low-to-mid 20s based on the 2026 EPS guidance and a business model centered on recurring data and analytics revenues, the stock continues to be evaluated in the context of other information services names and broader credit cycle dynamics.

Upcoming quarters and any further updates on growth initiatives, leverage and capital allocation are likely to inform how investors recalibrate their valuation expectations for TransUnion relative to domestic and international peers in the credit information and analytics space.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.